SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $53,476,000 |
| Positions | 3 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| DENALI THERAPEUTICS INC | DNLI | COM | $49,144,027 | 1,910,732 |
| SANA BIOTECHNOLOGY INC | SANA | COM | $2,637,619 | 755,736 |
| 8X8 INC NEW | EGHT | COM | $1,694,354 | 990,850 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.